Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230491 | 12723049 | 1 | I | 20160718 | 20160829 | 20160908 | 20160908 | EXP | CA-BAXTER-2016BAX046045 | BAXTER | 77.00 | YR | F | Y | 100.00000 | KG | 20160907 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230491 | 12723049 | 1 | PS | PROCYTOX (CYCLOPHOSPHAMIDE) 2000MG/VIAL | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 600 MG/M2, CYCLE-1 (STRENGTH 2 GRAMS) | Y | 5I010 | 12142 | 1270 | MG | POWDER FOR SOLUTION FOR INJECTION | Q3W | ||||
| 127230491 | 12723049 | 2 | SS | doxorubicin | DOXORUBICIN | 1 | Unknown | 60 MG/M2, CYCLE-1 | U | 0 | 127 | MG | /cycle | ||||||
| 127230491 | 12723049 | 3 | SS | APREPITANT. | APREPITANT | 1 | Oral | U | 0 | 125 | MG | ||||||||
| 127230491 | 12723049 | 4 | SS | APREPITANT. | APREPITANT | 1 | Oral | ON DAYS 2 AND 3 | U | 0 | 80 | MG | QD | ||||||
| 127230491 | 12723049 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 12 | MG | ||||||||
| 127230491 | 12723049 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | ON DAYS 2 AND 3 | U | 0 | 4 | MG | BID | ||||||
| 127230491 | 12723049 | 7 | SS | ondansetron | ONDANSETRON | 1 | Oral | U | 0 | 8 | MG | ||||||||
| 127230491 | 12723049 | 8 | SS | ondansetron | ONDANSETRON | 1 | Oral | DAY 1 | U | 0 | |||||||||
| 127230491 | 12723049 | 9 | SS | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Oral | Q4-6H PRN | U | 0 | 10 | MG | |||||||
| 127230491 | 12723049 | 10 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | INITIAL 12 HOURS POST TREATMENT | U | 0 | 2500 | MG | |||||||
| 127230491 | 12723049 | 11 | SS | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 127230491 | 12723049 | 12 | SS | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | Unknown | U | 0 | ||||||||||
| 127230491 | 12723049 | 13 | SS | EMEND | APREPITANT | 1 | Unknown | AT LUNCH | U | 0 | |||||||||
| 127230491 | 12723049 | 14 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 15 | C | pantoprazole | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 16 | C | perindopril | PERINDOPRIL | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 17 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 18 | C | GUAIFENESIN. | GUAIFENESIN | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 19 | C | codeine | CODEINE | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 20 | C | PHENTERMINE. | PHENTERMINE | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 21 | C | zopiclone | ZOPICLONE | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 22 | C | diclofenac | DICLOFENAC | 1 | Unknown | 0 | |||||||||||
| 127230491 | 12723049 | 23 | C | DESLORATADINE. | DESLORATADINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127230491 | 12723049 | 1 | Invasive breast carcinoma |
| 127230491 | 12723049 | 2 | Invasive breast carcinoma |
| 127230491 | 12723049 | 3 | Premedication |
| 127230491 | 12723049 | 4 | Antiemetic supportive care |
| 127230491 | 12723049 | 5 | Premedication |
| 127230491 | 12723049 | 6 | Antiemetic supportive care |
| 127230491 | 12723049 | 7 | Premedication |
| 127230491 | 12723049 | 8 | Antiemetic supportive care |
| 127230491 | 12723049 | 9 | Antiemetic supportive care |
| 127230491 | 12723049 | 10 | Headache |
| 127230491 | 12723049 | 11 | Headache |
| 127230491 | 12723049 | 12 | Headache |
| 127230491 | 12723049 | 13 | Nausea |
| 127230491 | 12723049 | 14 | Product used for unknown indication |
| 127230491 | 12723049 | 15 | Product used for unknown indication |
| 127230491 | 12723049 | 16 | Product used for unknown indication |
| 127230491 | 12723049 | 17 | Product used for unknown indication |
| 127230491 | 12723049 | 18 | Product used for unknown indication |
| 127230491 | 12723049 | 19 | Product used for unknown indication |
| 127230491 | 12723049 | 20 | Product used for unknown indication |
| 127230491 | 12723049 | 21 | Product used for unknown indication |
| 127230491 | 12723049 | 22 | Product used for unknown indication |
| 127230491 | 12723049 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127230491 | 12723049 | LT |
| 127230491 | 12723049 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127230491 | 12723049 | Hyponatraemia | |
| 127230491 | 12723049 | Hypophagia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127230491 | 12723049 | 1 | 20160718 | 20160718 | 0 | |
| 127230491 | 12723049 | 2 | 20160718 | 0 | ||
| 127230491 | 12723049 | 11 | 20160719 | 0 | ||
| 127230491 | 12723049 | 12 | 20160719 | 0 | ||
| 127230491 | 12723049 | 13 | 20160719 | 0 |